Zimmer Biomet Holdings Inc (ZBH)
120.18
-1.05
(-0.87%)
USD |
NYSE |
May 17, 16:00
120.16
-0.02
(-0.02%)
After-Hours: 20:00
Zimmer Biomet Holdings Research and Development Expense (Quarterly): 107.90M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 107.90M |
| December 31, 2023 | 113.30M |
| September 30, 2023 | 116.90M |
| June 30, 2023 | 118.10M |
| March 31, 2023 | 110.40M |
| December 31, 2022 | 108.00M |
| September 30, 2022 | 101.70M |
| June 30, 2022 | 99.40M |
| March 31, 2022 | 96.90M |
| December 31, 2021 | 96.00M |
| September 30, 2021 | 93.80M |
| June 30, 2021 | 165.00M |
| March 31, 2021 | 81.00M |
| December 31, 2020 | 50.80M |
| September 30, 2020 | 85.90M |
| June 30, 2020 | 87.70M |
| March 31, 2020 | 98.40M |
| December 31, 2019 | 121.10M |
| September 30, 2019 | 114.40M |
| June 30, 2019 | 112.10M |
| March 31, 2019 | 101.70M |
| December 31, 2018 | 101.20M |
| September 30, 2018 | 95.70M |
| June 30, 2018 | 99.10M |
| March 31, 2018 | 95.70M |
| Date | Value |
|---|---|
| December 31, 2017 | 95.00M |
| September 30, 2017 | 91.20M |
| June 30, 2017 | 92.60M |
| March 31, 2017 | 91.10M |
| December 31, 2016 | 95.70M |
| September 30, 2016 | 95.60M |
| June 30, 2016 | 88.60M |
| March 31, 2016 | 85.70M |
| December 31, 2015 | 85.90M |
| September 30, 2015 | 83.30M |
| June 30, 2015 | 51.30M |
| March 31, 2015 | 48.30M |
| December 31, 2014 | 50.80M |
| September 30, 2014 | 45.90M |
| June 30, 2014 | 48.00M |
| March 31, 2014 | 47.40M |
| December 31, 2013 | 46.00M |
| September 30, 2013 | 49.40M |
| June 30, 2013 | 54.90M |
| March 31, 2013 | 53.50M |
| December 31, 2012 | 55.30M |
| September 30, 2012 | 53.50M |
| June 30, 2012 | 57.20M |
| March 31, 2012 | 59.60M |
| December 31, 2011 | 64.90M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
50.80M
Minimum
Dec 2020
165.00M
Maximum
Jun 2021
103.94M
Average
104.80M
Median
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp | 368.00M |
| Align Technology Inc | 91.86M |
| Globus Medical Inc | 57.27M |
| Edwards Lifesciences Corp | 285.20M |
| ResMed Inc | 77.07M |